These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 9697721)

  • 21. Inhibition of human immunodeficiency virus type 1 replication in cytokine-stimulated monocytes/macrophages by combination therapy.
    Rusconi S; Merrill DP; Hirsch MS
    J Infect Dis; 1994 Dec; 170(6):1361-6. PubMed ID: 7527825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potent inhibition of HIV type 1 infection of mononuclear phagocytes by synthetic peptide analogs of HIV type 1 protease substrates.
    Dukes CS; Matthews TJ; Lambert DM; Dreyer GB; Petteway SR; Weinberg JB
    AIDS Res Hum Retroviruses; 1996 Jun; 12(9):777-82. PubMed ID: 8738429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The nontoxic tripeptide glycyl-prolyl-glycine amide inhibits the replication of human immunodeficiency virus type 1.
    Su J; Andersson E; Horal P; Naghavi MH; Palm A; Wu YP; Eriksson K; Jansson M; Wigzell H; Svennerholm B; Vahlne A
    J Hum Virol; 2001; 4(1):1-7. PubMed ID: 11213928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-1 protease inhibitors. A review for clinicians.
    Deeks SG; Smith M; Holodniy M; Kahn JO
    JAMA; 1997 Jan; 277(2):145-53. PubMed ID: 8990341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potent antiviral activity of amprenavir in primary macrophages infected by human immunodeficiency virus.
    Aquaro S; Guenci T; Di Santo F; Francesconi M; Caliò R; Perno CF
    Antiviral Res; 2004 Feb; 61(2):133-7. PubMed ID: 14670588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-human immunodeficiency virus 1 (HIV-1) activities of 3-deazaadenosine analogs: increased potency against 3'-azido-3'-deoxythymidine-resistant HIV-1 strains.
    Mayers DL; Mikovits JA; Joshi B; Hewlett IK; Estrada JS; Wolfe AD; Garcia GE; Doctor BP; Burke DS; Gordon RK
    Proc Natl Acad Sci U S A; 1995 Jan; 92(1):215-9. PubMed ID: 7816820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of human immunodeficiency virus type-1 replication in macrophages and H9 cells by free or liposome-encapsulated L-689,502, an inhibitor of the viral protease.
    Pretzer E; Flasher D; Düzgüneş N
    Antiviral Res; 1997 Mar; 34(1):1-15. PubMed ID: 9107381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of inhibitors of late stages of the replication of HIV in chronically infected macrophages.
    Perno CF; Aquaro S; Rosenwirth B; Balestra E; Peichl P; Billich A; Villani N; Caliò R
    J Leukoc Biol; 1994 Sep; 56(3):381-6. PubMed ID: 8083612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of pregnancy steroid hormones and zidovudine in inhibition of HIV type 1 replication in monocytoid and placental Hofbauer cells: implications for the prevention of maternal-fetal transmission of HIV.
    Lee AW; Mitra D; Laurence J
    AIDS Res Hum Retroviruses; 1997 Sep; 13(14):1235-42. PubMed ID: 9310291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissimilar attenuation of Candida albicans virulence properties by human immunodeficiency virus type 1 protease inhibitors.
    Gruber A; Berlit J; Speth C; Lass-Flörl C; Kofler G; Nagl M; Borg-von Zepelin M; Dierich MP; Würzner R
    Immunobiology; 1999 Sep; 201(1):133-44. PubMed ID: 10532286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ATP binding cassette multidrug transporters limit the anti-HIV activity of zidovudine and indinavir in infected human macrophages.
    Jorajuria S; Dereuddre-Bosquet N; Becher F; Martin S; Porcheray F; Garrigues A; Mabondzo A; Benech H; Grassi J; Orlowski S; Dormont D; Clayette P
    Antivir Ther; 2004 Aug; 9(4):519-28. PubMed ID: 15456083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antagonism between human immunodeficiency virus type 1 protease inhibitors indinavir and saquinavir in vitro.
    Merrill DP; Manion DJ; Chou TC; Hirsch MS
    J Infect Dis; 1997 Jul; 176(1):265-8. PubMed ID: 9207379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative assessment of antiretrovirals in human monocyte-macrophages and lymphoid cell lines acutely and chronically infected with the human immunodeficiency virus.
    Crowe SM; McGrath MS; Elbeik T; Kirihara J; Mills J
    J Med Virol; 1989 Nov; 29(3):176-80. PubMed ID: 2533247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and structural characterization of I84C and I84A mutations that are associated with high-level resistance to human immunodeficiency virus protease inhibitors and impair viral replication.
    Mo H; Parkin N; Stewart KD; Lu L; Dekhtyar T; Kempf DJ; Molla A
    Antimicrob Agents Chemother; 2007 Feb; 51(2):732-5. PubMed ID: 17101675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiviral profile of HIV inhibitors in macrophages: implications for therapy.
    Perno CF; Balestra E; Francesconi M; Abdelahad D; Caliò R; Balzarini J; Aquaro S
    Curr Top Med Chem; 2004; 4(9):1009-15. PubMed ID: 15134554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Naturally occurring decreased susceptibility of HIV-1 subtype G to protease inhibitors.
    Descamps D; Apetrei C; Collin G; Damond F; Simon F; Brun-Vézinet F
    AIDS; 1998 Jun; 12(9):1109-11. PubMed ID: 9662212
    [No Abstract]   [Full Text] [Related]  

  • 37. In vitro anti-human immunodeficiency virus (HIV) activities of transition state mimetic HIV protease inhibitors containing allophenylnorstatine.
    Kageyama S; Mimoto T; Murakawa Y; Nomizu M; Ford H; Shirasaka T; Gulnik S; Erickson J; Takada K; Hayashi H
    Antimicrob Agents Chemother; 1993 Apr; 37(4):810-7. PubMed ID: 8494379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Removal of human immunodeficiency virus type 1 (HIV-1) protease inhibitors from preparations of immature HIV-1 virions does not result in an increase in infectivity or the appearance of mature morphology.
    Humphrey RW; Ohagen A; Davis DA; Fukazawa T; Hayashi H; Höglund S; Mitsuya H; Yarchoan R
    Antimicrob Agents Chemother; 1997 May; 41(5):1017-23. PubMed ID: 9145862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-retroviral therapy in HIV-infected patients: in vitro effects of AZT and saquinavir on the response of CD4 and CD8 lymphocytes to interleukin-7.
    Beq S; Bugault F; Colle JH; Lambotte O; Delfraissy JF; Thèze J
    Eur Cytokine Netw; 2005 Dec; 16(4):293-9. PubMed ID: 16464744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human immunodeficiency virus type 1 induces cellular polarization, intercellular adhesion molecule-1 redistribution, and multinucleated giant cell generation in human primary monocytes but not in monocyte-derived macrophages.
    Fais S; Borghi P; Gherardi G; Logozzi M; Belardelli F; Gessani S
    Lab Invest; 1996 Dec; 75(6):783-90. PubMed ID: 8973473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.